Dechra Pharmaceuticals Plc
(LSE) DPH
This security has been delisted. This page is retained for historical reference.
DPH News
3 FTSE Shares Hitting New Highs
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowDPH Financials
Key Financial Metrics (TTM)
Gross Margin
56%
Operating Margin
1%
Net Income Margin
-4%
Return on Equity
-4%
Return on Capital
0%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
32.33%
Payout Ratio
-1.85%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$426.30M
Operating Income
$6.30M
EBITDA
$86.70M
Operating Cash Flow
$63.60M
Capital Expenditure
$30.30M
Free Cash Flow
$33.30M
Cash & ST Invst.
$74.40M
Total Debt
$504.50M
Dechra Pharmaceuticals Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$384.10M
+24.6%
Gross Profit
$211.10M
+20.5%
Gross Margin
54.96%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
2,457
N/A
Net Income
$50.50M
-256.8%
EBITDA
$15.90M
-121.1%
Quarterly Fundamentals
Net Cash
$430.10M
-114.8%
Accounts Receivable
$144.20M
N/A
Inventory
$217.30M
+45.4%
Long Term Debt
$500.60M
+58.7%
Short Term Debt
$3.90M
+25.8%
Return on Assets
-1.78%
N/A
Return on Invested Capital
0.45%
N/A
Free Cash Flow
$200.00K
-100.8%
Operating Cash Flow
$12.10M
-71.7%